Skript Technologies Inc.

Skript helps healthcare students store their growing knowledge bank through local markdown files on a simple & fast smartphone app.

Co-Founder and CEO

University of California, San Francisco

Designed and built a novel anti-cancer T cell therapy to kill acute myeloid leukemia cells with zero collateral damage. Specifically, used a "Synthetic Notch Receptor" genetic platform for Boolean-gating behavior and single tissue targeting. Awarded UCSF Dean's Prize for best project.

Biochemical Researcher | Cell Engineering and Gene Editing

The National Institutes of Health

Studied the epigenetic levers of inflammation in dementia. Specifically, showed that the transcription factor IRF8 is critical to immune cell activation in the brain.

Taplio

Keith Sakata, M.D.'s Linkedin Analytics

Keith Sakata, M.D.

Want to drive more opportunities from LinkedIn?

Taplio

.css-1jgreyo{background-image:linear-gradient(284deg, rgba(39,43,72,1) 0%, rgba(33,47,183,1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Keith Sakata, M.D.'s Linkedin Analytics

Keith Sakata, M.D.

Want to drive more opportunities from LinkedIn?

Keith Sakata, M.D.'s Linkedin Analytics